Related Experiment Video

Updated: Jul 10, 2026

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry
08:04

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Published on: June 10, 2025

Pharmacogenomics of platelet responsiveness to aspirin

Nauder Faraday1, Diane M Becker, Lewis C Becker

  • 1Johns Hopkins University School of Medicine, Department of Anesthesiology/Critical Care Medicine, Division of Cardiac Surgical Intensive Care, 298 Meyer Bldg, 600 N Wolfe St, Baltimore, MD 21287, USA. nfaraday@jhmi.edu

Pharmacogenomics
|November 6, 2007
PubMed

Insights

Individual responses to aspirin vary significantly, impacting cardiovascular protection. Identifying genetic factors behind this variability is key to personalized antiplatelet therapy and reducing risks.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacogenomics
  • Platelet Biology

Background:

  • Aspirin is a globally prevalent medication for cardiovascular protection.
  • Individual variability in aspirin's platelet suppression is linked to higher risks of heart attack, stroke, and cardiovascular death.
  • Platelet response to aspirin is a complex trait influenced by multiple genes and pathways, with non-cyclooxygenase-1 (COX-1) related factors being more significant.

Purpose of the Study:

  • To investigate the genetic underpinnings of variable platelet response to aspirin.
  • To identify specific gene variants contributing to aspirin response phenotypes.
  • To establish the relationship between genotype, aspirin response, and clinical outcomes for personalized antiplatelet therapy.

Main Methods:

  • Phenotypic characterization of aspirin response in individuals.
  • Genetic analysis to identify relevant gene variants.
  • Correlation of genotype with aspirin response and clinical events.

Main Results:

  • Aspirin response variability is genetically determined.
  • Specific gene variants influencing aspirin response phenotypes were identified (details not provided in abstract).
  • Understanding these genetic factors is crucial for predicting clinical outcomes.

Conclusions:

  • Personalized antiplatelet therapy based on genetic profiling can optimize aspirin's benefits.
  • Tailoring aspirin dosage or alternative therapies based on genotype can maximize antithrombotic effects while minimizing bleeding risks.
  • Further research into genotype-phenotype correlations will refine personalized cardiovascular protection strategies.

More Related Videos

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene07:00

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

Published on: April 1, 2019

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...